Efficacy of Sitagliptin on glycaemic control in drug naive patients with type 2 diabetes (STRICT-2).
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Sitagliptin (Primary) ; Meglitinide; Metformin; Nateglinide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms STRICT-2
- 07 Mar 2018 Status changed from active, no longer recruiting to completed.
- 18 Apr 2013 Planned end date changed from 30 Jun 2013 to 31 Aug 2013 as reported by University Hospital Medical Information Network - Japan.
- 03 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.